Corient Capital Partners, LLC Exact Sciences Corp Transaction History

Corient Capital Partners, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$72.5 - $100.68 $181,902 - $252,606	-2,509 Closed	0 $0
Q3 2021 Nov 16, 2021	BUY	$90.24 - $124.05 $44,488 - $61,156	493 Added 24.45%	2,509 $239,000
Q2 2021 Aug 16, 2021	SELL	$93.66 - $139.27 $9,740 - $14,484	-104 Reduced 4.91%	2,016 $251,000
Q1 2021 May 17, 2021	BUY	$116.57 - $155.01 $37,652 - $50,068	323 Added 17.97%	2,120 $279,000
Q4 2020 Feb 12, 2021	BUY	$99.61 - $142.12 $178,999 - $255,389	1,797 New	1,797 $238,000
Q1 2020 May 06, 2020	SELL	$37.9 - $104.44 $168,351 - $463,922	-4,442 Closed	0 $0
Q4 2019 Feb 04, 2020	BUY	$77.66 - $99.74 $6,834 - $8,777	88 Added 2.02%	4,442 $411,000
Q3 2019 Nov 06, 2019	BUY	$90.37 - $122.49 $179,384 - $243,142	1,985 Added 83.79%	4,354 $393,000
Q2 2019 Aug 08, 2019	BUY	$89.51 - $118.04 $212,049 - $279,636	2,369 New	2,369 $280,000

673

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.2B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Corient Capital Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Corient Capital Partners, LLC with notifications on news.